Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
45.9M
-
Shares change
-
+201K
-
Total reported value, excl. options
-
$3.19B
-
Value change
-
+$27.2M
-
Put/Call ratio
-
2.28
-
Number of buys
-
81
-
Number of sells
-
-58
-
Price
-
$69.55
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q1 2024
159 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q1 2024.
Arcellx, Inc. - COMMON STOCK (ACLX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.9M shares
of 55.4M outstanding shares and own 82.8% of the company stock.
Largest 10 shareholders include FMR LLC (5.39M shares), PERCEPTIVE ADVISORS LLC (3.93M shares), Paradigm Biocapital Advisors LP (3.82M shares), NEA Management Company, LLC (3.75M shares), BlackRock Inc. (3.07M shares), SR ONE CAPITAL MANAGEMENT, LP (2.35M shares), VANGUARD GROUP INC (2.23M shares), STATE STREET CORP (1.89M shares), Cormorant Asset Management, LP (1.78M shares), and SUVRETTA CAPITAL MANAGEMENT, LLC (1.56M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.